O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

Weckesser, M; Langen, K J; Rickert, C H; Kloska, S; Straeter, R; Hamacher, K; Kurlemann, G; Wassmann, H; Coenen, H H; Schober, O

Weckesser, M; Langen, K J; Rickert, C H; Kloska, S; Straeter, R; Hamacher, K; Kurlemann, G; Wassmann, H; Coenen, H H; Schober, O.

Affiliation

Weckesser M; Department of Nuclear Medicine, Münster University, Albert-Schweitzer-Strasse 33, 48149, Münster, Germany. m.weckesser@uni-muenster.de

Eur J Nucl Med Mol Imaging ; 32(4): 422-9, 2005 Apr.

Article in En | MEDLINE | ID: mdl-15650870

Subject(s)

Brain Neoplasms/diagnostic imaging; Brain Neoplasms/metabolism; Fluorine Radioisotopes/pharmacokinetics; Positron-Emission Tomography/methods; Tyrosine/analogs & derivatives; Tyrosine/pharmacokinetics; Adolescent; Adult; Aged; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Radiopharmaceuticals/pharmacokinetics; Reproducibility of Results; Sensitivity and Specificity

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tyrosine / Brain Neoplasms / Fluorine Radioisotopes / Positron-Emission Tomography Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2005 Type: Article Affiliation country: Germany

Search on Google

XML

PubMed Links